Company profilePharmaceutical#83 of 1,318 in Pakistan✓ No DRAP alerts

Winlet Pharmaceuticals (Pvt) Ltd.

Pharmaceutical company · 187 brands · 179 molecules

Ranked #13 of 106 companies in Antidepressants

187 registered products 57 pharmaceutical brands 179 distinct molecules 0 DRAP alerts

Company overview

187
registered products
57
pharmaceutical brands
179
distinct molecules
12
therapeutic classes
0
DRAP alerts

Winlet Pharmaceuticals (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 187 product registrations across 179 distinct molecules. It is the 83rd largest registrant in Pakistan by product count, and ranks 13th of 106 in Antidepressants. Its portfolio is concentrated in Antidepressants and Antiinflammatory And Antirheumatic Products. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Winlet

112 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

111
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
2025110
20261

Top molecules by brand count

Amlodipine9 brands
Paracetamol7 brands
Ondansetron5 brands
Azithromycin4 brands
Cefixime4 brands
Omeprazole4 brands
Olanzapine4 brands
Linezolid4 brands
Voriconazole4 brands

Therapeutic classes

Antidepressants · 7Antiinflammatory And Antirheumatic Products · 7Angiotensin-Ii Antagonists, Combinations · 5Antianemic, Iron Preparations · 4Antiepileptics · 4Antimycotics Systemic Use · 4Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Other Beta-Lactam, Cephalosporins & Penems · 4Antivirals For Systemic Use · 3Quinolone Antibacterials · 3Other Anti-Baterials · 3Antiemetics & Antinauseants · 3

Conditions treated

General Infections · 1Vomiting/Emesis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official184 products · Rs 34.08 – Rs 4,763.97
DVAGO1 products · Rs 427.56 – Rs 427.56
Servaid4 products · Rs 172.8 – Rs 450
Median across source: Rs 427.56

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 158 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAgomelatine
Horizon Pharmaceuticals (Pvt) Limited holds 98 molecules not in this portfolio
AlbendazoleAmoxicillinAmoxycillin BaseArtemether Ii) LumefantrineArtesunateAscorbic Acid
GETZ PHARMA PAKISTAN (PVT) LTD. holds 233 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAdrenalineAlbendazoleAmitriptyline

Get the full profile for Winlet

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.